Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Subst Abuse Treat ; 65: 13-9, 2016 06.
Article in English | MEDLINE | ID: mdl-26517954

ABSTRACT

The impact of Motivational Interviewing (MI) on risky behaviors of incarcerated adolescents and adults has been investigated with promising results. Findings suggest that MI reduces substance use, improves motivation and confidence to reduce use, and decreases risky behaviors. The current study investigated the impact of MI on general, alcohol-related, and marijuana-related delinquent behaviors in incarcerated adolescents. Participants in the study were incarcerated adolescents in a state correctional facility in the Northeast region and were assessed as part of a larger randomized clinical trial. Adolescents were randomly assigned to receive MI or relaxation therapy (RT) (N=189) treatment. Delinquent behaviors and depressive symptomatology were measured using the Delinquent Activities Scale (DAS; Reavy, Stein, Paiva, Quina, & Rossi, 2012) and the Center for Epidemiological Studies-Depression scale (CES-D; Radloff, 1991) respectively. Findings indicate that depression moderated treatment effects. Compared to RT, MI was better at reducing predatory aggression and alcohol-related predatory aggression 3 months post-release when depressive symptoms were low. Identifying an efficacious treatment for these adolescents may benefit society in that it may decrease crimes against persons (i.e., predatory aggression) post release.


Subject(s)
Alcoholism/therapy , Marijuana Abuse/therapy , Motivational Interviewing/methods , Prisoners/psychology , Adolescent , Depression/prevention & control , Humans , Psychiatric Status Rating Scales , Relaxation Therapy , Risk-Taking , Treatment Outcome
2.
Bioorg Med Chem Lett ; 21(1): 492-6, 2011 Jan 01.
Article in English | MEDLINE | ID: mdl-21094606

ABSTRACT

Small molecule isoindoline and tetrahydroisoquinoline derivatives have been identified as selective agonists of human peroxisome proliferator-activated receptor δ (PPARδ. Compound 18 demonstrated efficacy in a biomarker for increased fatty acid oxidation, with upregulation of pyruvate dehydrogenase kinase, isozyme 4 (PDK4) in human primary myotubes.


Subject(s)
Indoles/chemistry , PPAR delta/agonists , Tetrahydroisoquinolines/chemistry , Binding Sites , Catalytic Domain , Computer Simulation , Humans , Indoles/chemical synthesis , Indoles/pharmacology , PPAR delta/metabolism , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , Pyruvate Dehydrogenase Acetyl-Transferring Kinase , Structure-Activity Relationship , Tetrahydroisoquinolines/chemical synthesis , Tetrahydroisoquinolines/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...